Physicians’ Opinions Survey on FDA’s Bydureon Approval

2012-03-06

Physicians were asked to assess their impressions of Bydureon in terms of efficacy, safety, tolerability, expected use, and other important factors. Key questions are broken down by specialty or familiarity to highlight difference in physician perceptions

Highlights

Datamonitor anticipates that the initial enthusiasm will ultimately be muted once physicians gain experience with the drug. Nevertheless, a once-weekly antidiabetic agent clearly represents an attractive option for type 2 diabetes patients, and physicians expect the drug to be a welcome addition to their armamentarium.

FDA’s Bydureon Approval

Published: February 2012
Price
: Single User License US$3800            Corporate User License – US$9500

                    Request Sample


Your key questions answered
  • Assess physicians’ opinions of Bydureon as compared with Amylin’s twice-daily Byetta (exenatide) and Novo Nordisk’s once-daily Victoza (liraglutide)
  • Determine physicians’ expectations for Bydureon’s uptake, line of therapy, and use in combination with other antidiabetics
  • Evaluate how Bydureon may expand the overall market for GLP-1 agonists

Table of Contents

BYDUREON FDA APPROVAL: PHYSICIAN OPINION
Background

SURVEY RESULTS
Demographics
Limited familiarity with PCPs could present a marketing challenge
Impressions of Bydureon’s efficacy differ based on familiarity
Tolerability issues trump safety concerns among physicians familiar with Bydureon
High expectations for Bydureon use will likely come down with increased experience
Endocrinologists expect to use Bydureon in earlier line of therapy compared to PCPs
Combination use with oral antidiabetics is likely
Physicians expect Bydureon to expand the GLP-1 agonist market
Conclusion

APPENDIX
Report methodology
Datamonitor consulting

Disclaimer

List of Figures

Figure: On average, how many patients with type 2 diabetes do you treat per month?
Figure: How familiar are you with Bydureon (once-weekly exenatide)?
Figure: For each attribute below, please select the one drug that you would prefer to prescribe, based on performance (or predicted performance) on that attribute
Figure: Please select the one drug that you would prefer to prescribe, based on efficacy (HbA1c lowering ability)
Figure: Please rank the following potential safety (and tolerability) issues you are most concerned about with Bydureon on a scale of 1 to 7, where 1 is the issue of greatest concern and 7 is the issue of least concern
Figure: Please select the one drug that you would prefer to prescribe, based on injection device
Figure: Where in the treatment algorithm do you think you will most commonly prescribe Bydureon?
Figure: Please consider your hypothetical Bydureon-treated patient population a year post-launch. What percentage of the Bydureon-treated patient population do you expect to have previously been treated with each of the following options?
Figure: Please choose up to three drug classes with which Bydureon could be used in combination. If there are more than three classes, please select the three most likely
Figure: Please give your opinion on how the introduction of Bydureon, and any other market trends, will impact on the number of patients on GLP-1 agonists in the US

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
More Reports
Title Price Buy Now

Global Over-the-Counter Drug Market 2016-2020

OTC drugs are medicines that can be bought without a prescription from a doctor because the US FDA considers them safe for use without medical supervision. These drugs are used to treat conditions that do not necessarily require a doctor's advice, such as pain, itches, cough and cold, sleeping problems, smoking cessation, weight problems, gastrointestinal problems, and tooth decay. They are sold through hospitals, pharmaceutical stores, grocery stores, catalogs, and online retail stores. The analysts forecast global over-the-counter (OTC) drug market to grow at a CAGR of 6.19% during the period 2016-2020. Covered in this report The report covers present scenario and the growth prospects of the global over-the-counter (OTC) drug market for 2016-2020. To calculate the market size, t......
$2500

Global Premature Ejaculation Treatment Market 2016-2020

Premature ejaculation refers to the discharge of semen shortly before or after penetration during sexual intercourse, thereby leading to an unsatisfactory sex life and affecting the patient's relationship with their partner. There is no proper cause that can be associated with the condition. However, personal distress and anxiety are possible attributes. The analyst forecast global premature ejaculation treatment market to grow at a CAGR of 9.65% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global premature ejaculation treatment market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of premature ejaculation drugs and premature ejaculation solutions.......
$2500

Global Parenteral Products Packaging Market 2016-2020

Parenteral packaging refers as an economical means of providing protection, presentation, identification, information, and convenience for parenteral products from the moment of production until it is used to the injectable route of drug administration. The sterility of the drug inside the container is essential as parenteral drugs are injected directly into the body tissue. So, packaging should protect and avoid any physical, chemical and biological contamination of the drug during the opening of the packaging. The common packaging material used for parenteral packaging are made of glass and plastic. The primary parenteral packaging for dosing and filling includes ampules, tubes, vials, inhalers, and syringes. The analyst forecast global parenteral products packaging market to grow at ......
$2500

Global Pneumococcal Vaccine Market 2016-2020

Pneumococcus (Streptococcus pneumoniae), a pathogenic bacterium, is the leading cause of serious illness worldwide. It is the major cause of pneumonia, blood infections, meningitis, sinusitis, and middle ear infections (otitis media). Pneumococcal infections affect children younger than five years and older people (65 years and older), and it is among the leading infectious disease. It kills almost 1.6 million people (including over 800,000 children under five years) every year. It can be prevented by vaccination and involves the introduction of a dead or weakened antigen into the human body. This produces lymphocytes to counter the infection and any future invasions by that antigen. The analyst forecast global pneumococcal vaccine market to grow at a CAGR of 13.69% during the period 20......
$2500

Global Biosimilars Market 2016-2020

Biosimilars are defined as the follow-on versions of original biological medicines. These are separately developed after the patent protecting the original product has expired. Biosimilars are intended to have the same MOA as original biological drugs and are designed to treat the same diseases as the innovator's product. They have many similarities, but are not identical to, the reference biopharmaceutical product. The analyst forecast global biosimilars market to grow at a CAGR of 55.52% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global biosimilars market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of products such as somatropin, erythropoiet......
$2500

Global Pain Management Drugs Market 2016-2020

Pain is defined as a complex medical problem that can have profound effects not only on one's physical but also mental well-being. Pain management is a branch of medicine, which employs approach for easing the suffering and improving the quality of life of individuals suffering from pain. It can be simple or complex type, depending on the cause of pain. Pain management comprises of a variety of skills and techniques used for the treatment of pain. The analyst forecast global pain management drugs market to grow at a CAGR of 4.97% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global pain management drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from th......
$2500

Global Emergency Contraceptive Pills Market 2016-2020

EC pills are short-term contraceptives used in the initial days after sexual intercourse to prevent pregnancy due to various uncertainties such as unprotected intercourse, coerced sex, forgotten pills, and condom breakage. These pills are only effective before the fertilization of the ovum by the sperm. As per WHO, levonorgestrel-based EC pills are ideal for users when taken in a single dose. These pills are not effective after five days once the ovulation process begins. Factors such as urbanization, increasing acceptance of sex, and growing visibility of EC pills are increasing their penetration in emerging economies. The analyst forecast global EC pills market to grow at a CAGR of 1.93% during the period 2016-2020. Covered in this report This report covers the present scenario ......
$2500

Global Asthma Therapeutics Market 2016-2020

Increasing allergic rhinitis is a major factor for allergic asthma leading to increase in research for the development of allergic immunotherapies for the treatment of asthma. The global asthma therapeutics market will observe a moderate growth during the forecast period because of loss of patent exclusivity of the major drugs, allowing the entry of generics into the market. This will lead to the erosion of the market share of the major asthma drugs. However, the presence of late-stage pipeline molecules will drive the market. An increase in the prevalence of asthma and the use of combination drugs will drive the growth of the market during the forecast period. The analyst forecast global asthma therapeutics market to grow at a CAGR of 4.31% during the period 2016-2020. Covered in th......
$2500

Global Medical Membranes Market 2016-2020

Medical membranes are majorly used for separation of the feed stream. The feed stream is passed through the membrane, which allows selective constituents to pass through, depending on its pore size, whereas others are stopped back on the surface of the membrane. The elements that pass through are known as permeate and the ones that are retained back are known as concentrate. Different types of membranes are used in the medical industry depending on the size of their pores. The analyst forecast global medical membranes market to grow at a CAGR of 9.61% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global medical membranes market for 2016-2020. The report also presents the vendor landscape and a correspond......
$2500

Global Testosterone Replacement Therapy Market 2016-2020

Testosterone replacement therapy, also called androgen replacement therapy, is typically used to treat hypogonadism. Testosterone, a hormone produced by the testes, is responsible for the development of secondary sexual characters in men. The levels of testosterone decrease gradually with age, but sometimes this decline is seen even in young men, leading to a condition known as hypogonadism. This can be treated with external supply of testosterone in the form of gels, patches, injectable, or oral drugs. The analyst forecast global testosterone replacement therapy market is gradually declining and will post a CAGR of (3.35) % during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global testosterone replacement th......
$2500